Physician profile
Allison Bray Pariyadath
NPI 1588957955
$2,476.74
in general payments reported to CMS, 2019-2025
17 companies · $666 in 2025
The $666 reported for 2025 was more than what a typical Ophthalmic Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $299).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $72.22 · 2021: $313 · 2022: $218 · 2023: $415 · 2024: $687 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,751 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,750.56 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $611.90 | 2021-2025 | Clareon, Rocklatan, Simbrinza |
| Abbvie INC. | $507.88 | 2022-2025 | |
| New World Medical,INC. | $233.46 | 2024-2025 | Streamline, Kahook Dual Blade, Clearpath |
| Oyster Point Pharma, INC. | $190.63 | 2023-2025 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $182.67 | 2019-2023 | Cequa |
| Bausch & Lomb Americas INC. | $143.74 | 2022-2025 | Vyzulta, Miebo, Infuse |
| Johnson & Johnson Surgical Vision, INC. | $124.41 | 2021 | |
| Aerie Pharmaceuticals, INC. | $97.23 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $96.03 | 2024-2025 | Xdemvy |
| Allergan, INC. | $51.59 | 2019-2020 | |
| Harrow Eye, LLC | $46.40 | 2024-2025 | Vevye |
| Amgen INC. | $41.38 | 2024-2025 | Tepezza |
| Novartis Pharmaceuticals Corporation | $39.42 | 2021 | |
| Astellas Pharma US INC | $33.83 | 2025 | Izervay |
| Genentech USA, INC. | $32.27 | 2025 | Susvimo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $28.59 | 2023 | Eylea Hd |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Pariyadath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.